Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinghua Pharmaceutical Group is a prominent Chinese pharmaceutical company headquartered in Nantong, Jiangsu. Established through the reorganization of the former Nantong Pharmaceutical Factory (founded in 1957), the company specializes in the research, development, and manufacturing of traditional Chinese medicines (TCM), chemical APIs, and finished dosage forms. Its core product portfolio includes well-known TCMs like Wangshi Baochi Pills and Ji Desheng Snake Medicine, as well as essential chemical drugs such as Phenobarbital and Fluorouracil. The company is listed on the Shenzhen Stock Exchange and operates several subsidiaries focused on API production and pharmaceutical distribution. Jinghua Pharmaceutical is recognized as a 'Time-Honored Brand of China' and maintains a strong presence in both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Pharmaceutical Factory.